Tools for assessing outcomes in studies of chronic cough: CHEST Guideline Expert Panel report

Chest

Volumn 147, Issue 3, 2015, Pages 804-814

  Boulet, Louis Philippe ^a   Coeytaux, Remy R ^b   McCrory, Douglas C ^c   French, Cynthia T ^d   Chang, Anne B ^e   Birring, Surinder S ^f   Smith, Jaclyn ^g   Diekemper, Rebecca L ^h   Rubin, Bruce ⁱ   Irwin, Richard S ^j  

^a LAVAL UNIVERSITY   (Canada)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^d UMASS MEMORIAL MEDICAL CENTER   (United States)

^e ROYAL CHILDREN'S HOSPITAL   (Australia)

^f KING'S COLLEGE LONDON   (United Kingdom)

^g MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^h American College of Chest Physicians   (United States)

ⁱ VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^j UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHRONIC COUGH; COMPARATIVE EFFECTIVENESS; COUGH SPECIFIC QUALITY OF LIFE QUESTIONNAIRE; DISEASE SEVERITY; HUMAN; LEICESTER COUGH QUESTIONNAIRE; MORBIDITY; OUTCOME ASSESSMENT; PARENT COUGH SPECIFIC QUALITY OF LIFE QUESTIONNAIRE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; VISUAL ANALOG SCALE; ADOLESCENT; ADULT; AGED; CHILD; CHRONIC DISEASE; COUGH; INFANT; MEDICAL RESEARCH; MIDDLE AGED; PRESCHOOL CHILD; PUBLICATION; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ANTITUSSIVE AGENT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTITUSSIVE AGENTS; BIOMEDICAL RESEARCH; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; COUGH; HUMANS; INFANT; MIDDLE AGED; PATIENT OUTCOME ASSESSMENT; PERIODICALS AS TOPIC; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VISUAL ANALOG SCALE; YOUNG ADULT;

EID: 84924911623     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.14-2506     Document Type: Article

References (111)

1. Centers for Disease Control and Prevention (CDC), National Center for Health Statistics. National Hospital Ambulatory Medical Care Survey: 2010 Outpatient Department Summary Tables. Atlanta, GA: Centers for Disease Control and Prevention; 2013.
2. Irwin RS, Baumann MH, Bolser DC, et al; American College of Chest Physicians (ACCP). Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines. C hest. 2006;129(1-suppl):1S-23S.
3. Irwin RS, Boulet LP, Cloutier MM, et al. Managing cough as a defense mechanism and as a symptom: a consensus panel report of the American College of Chest Physicians. Chest. 1998;114(2-suppl):133S-181S.
4. Morice AH, McGarvey L, Pavord I; British Thoracic Society Cough Guideline Group. Recommendations for the management of cough in adults. Thorax. 2006;61(suppl 1):i1-i24.
5. Schmit KM, Coeytaux RR, Goode AP, et al. Evaluating cough assessment tools: a systematic review. Chest. 2013;144(6):1819-1826.
6. Irwin RS. Assessing cough severity and efficacy of therapy in clinical research: ACCP evidence-based clinical practice guidelines. C hest. 2006;129(1-suppl):232S-237S.
7. Lewis SZ, Diekemper RL, French CT, Gold PM, Irwin RS; CHEST Expert Cough Panel; CHEST Expert Cough Panel. Methodologies for the development of the management of cough: CHEST guideline and expert panel report. Chest. 2014;146(5):1395-1402.
8. Lewis SZ, Diekemper R, Ornelas J, Casey KR. Methodologies for the development of CHEST guidelines and expert panel reports. Chest. 2014;146(1):182-192.
9. McCrory DC, Coeytaux RR, Yancy WS, et al. Assessment and Management of Chronic Cough. Rockville, MD: Agency for Healthcare Research and Quality; 2013.
10. Ahmed N, Sutcliffe A, Tipper C. Feasibility study: honey for treatment of cough in children. Pediatr Rep. 2013;5(2):31-34.
11. Albrecht H, Vernon M, Solomon G. Patient-reported outcomes to assess the efficacy of extended-release guaifenesin for the treatment of acute respiratory tract infection symptoms. Respir Res. 2012;13:118.
12. Barton A, Gaydecki P, Holt K, Smith JA. Data reduction for cough studies using distribution of audio frequency content. Cough. 2012;8(1):12.
13. Bhattacharya M, Joshi N, Yadav S. To compare the effect of dextromethorphan, promethazine and placebo on nocturnal cough in children aged 1-12 y with upper respiratory infections: a randomized controlled trial. Indian J Pediatr. 2013;80(11):891-895.
14. Cai C, He MZ, Zhong SQ, et al. Add-on montelukast vs double-dose budesonide in nonasthmatic eosinophilic bronchitis: a pilot study. Respir Med. 2012;106(10):1369-1375.
15. Cohen HA, Rozen J, Kristal H, et al. Effect of honey on nocturnal cough and sleep quality: a double-blind, randomized, placebo-controlled study. Pediatrics. 2012;130(3):465-471.
16. Faruqi S, Sedman P, Jackson W, Molyneux I, Morice AH. Fundoplication in chronic intractable cough. Cough. 2012;8(1):3.
17. Hareendran A, Palsgrove AC, Mocarski M, et al. The development of a patient-reported outcome measure for assessing nighttime symptoms of chronic obstructive pulmonary disease. Health Qual Life Outcomes. 2013;11:104.
18. Hrisanfow E, Hägglund D. Impact of cough and urinary incontinence on quality of life in women and men with chronic obstructive pulmonary disease. J Clin Nurs. 2013;22(1-2):97-105.
19. Kavitt RT, Higginbotham T, Slaughter JC, et al. Symptom reports are not reliable during ambulatory reflux monitoring. Am J Gastroenterol. 2012;107(12):1826-1832.
20. Koskela HO, Purokivi MK. Capability of hypertonic saline cough provocation test to predict the response to inhaled corticosteroids in chronic cough: a prospective, open-label study. Cough. 2013;9:15.
21. Larson S, Comina G, Gilman RH, Tracey BH, Bravard M, López JW. Validation of an automated cough detection algorithm for tracking recovery of pulmonary tuberculosis patients. PLoS One. 2012;7(10):e46229.
22. Lee KK, Matos S, Evans DH, White P, Pavord ID, Birring SS. A longitudinal assessment of acute cough. Am J Respir Crit Care Med. 2013;187(9):991-997.
23. Molassiotis A, Ellis J, Wagland R, et al. The Manchester cough in lung cancer scale: the development and preliminary validation of a new assessment tool. J Pain Symptom Manage. 2013;45(2):179-190.
24. Sumner H, Woodcock A, Kolsum U, et al. Predictors of objective cough frequency in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;187(9):943-949.
25. Anderson-James S, Marchant JM, Acworth JP, Turner C, Chang AB. Inhaled corticosteroids for subacute cough in children. Cochrane Database Syst Rev. 2013;(2):CD008888.
26. Chang AB, Robertson CF, van Asperen PP, et al. A cough algorithm for chronic cough in children: a multicenter, randomized controlled study. Pediatrics. 2013;131(5):e1576-e1583.
27. Kahrilas PJ, Howden CW, Hughes N, Molloy-Bland M. Response of chronic cough to acid-suppressive therapy in patients with gastroesophageal reflux disease. Chest. 2013;143(3):605-612.
28. Lechtzin N, Hilliard ME, Horton MR. Validation of the Cough Quality-of-Life Questionnaire in patients with idiopathic pulmonary fibrosis. Chest. 2013;143(6):1745-1749.
29. Lee KK, Savani A, Matos S, Evans DH, Pavord ID, Birring SS. Four-hour cough frequency monitoring in chronic cough. Chest. 2012;142(5):1237-1243.
30. Newcombe PA, Sheffield JK, Chang AB. Parent cough-specific quality of life: development and validation of a short form. J Allergy Clin Immunol. 2013;131(4):1069-1074.
31. Ogawa H, Fujimura M, Takeuchi Y, Makimura K. Clinical experience with low-dose itraconazole in chronic idiopathic cough. Cough. 2013;9(1):1.
32. Ryan NM, Birring SS, Gibson PG. Gabapentin for refractory chronic cough: a randomised, double-blind, placebo-controlled trial. Lancet. 2012;380(9853):1583-1589.
33. Shembel AC, Rosen CA, Zullo TG, Gartner-Schmidt JL. Development and validation of the cough severity index: a severity index for chronic cough related to the upper airway. Laryngoscope. 2013;123(8):1931-1936.
34. Sundar KM, Daly SE, Willis AM. A longitudinal study of CPAP therapy for patients with chronic cough and obstructive sleep apnoea. Cough. 2013;9(1):19.
35. Sunger K, Powley W, Kelsall A, Sumner H, Murdoch R, Smith JA. Objective measurement of cough in otherwise healthy volunteers with acute cough. Eur Respir J. 2013;41(2):277-284.
36. Van de Kerkhove C, Goeminne PC, Van Bleyenbergh P, Dupont LJ. A cohort description and analysis of the effect of gabapentin on idiopathic cough. Cough. 2012;8(1):9.
37. Agency for Healthcare Research and Quality. Methods Guide for Effectiveness and Comparative Effectiveness Reviews. Rockville, MD: Agency for Healthcare Research and Quality; 2014.
38. Agency for Healthcare Research and Quality. Methods Guide for Medical Test Reviews. Rockville, MD: Agency for Healthcare Research and Quality; 2012.
39. French CT, Irwin RS, Fletcher KE, Adams TM. Evaluation of a cough-specific quality-of-life questionnaire. Chest. 2002;121(4):1123-1131.
40. Birring SS, Prudon B, Carr AJ, Singh SJ, Morgan MD, Pavord ID. Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ). Thorax. 2003;58(4):339-343.
41. Fletcher KE, French CT, Irwin RS, Corapi KM, Norman GR. A prospective global measure, the Punum Ladder, provides more valid assessments of quality of life than a retrospective transition measure. J Clin Epidemiol. 2010;63(10):1123-1131.
42. Berkhof FF, Boom LN, ten Hertog NE, Uil SM, Kerstjens HA, van den Berg JW. The validity and precision of the Leicester Cough Questionnaire in COPD patients with chronic cough. Health Qual Life Outcomes. 2012;10:4.
43. Birring SS, Matos S, Patel RB, Prudon B, Evans DH, Pavord ID. Cough frequency, cough sensitivity and health status in patients with chronic cough. Respir Med. 2006;100(6):1105-1109.
44. Decalmer SC, Webster D, Kelsall AA, McGuinness K, Woodcock AA, Smith JA. Chronic cough: how do cough reflex sensitivity and subjective assessments correlate with objective cough counts during ambulatory monitoring? Thorax. 2007;62(4):329-334.
45. Faruqi S, Thompson R, Wright C, Sheedy W, Morice AH. Quantifying chronic cough: objective versus subjective measurements. Respirology. 2011;16(2):314-320.
46. Huisman AN, Wu MZ, Uil SM, van den Berg JW. Reliability and validity of a Dutch version of the Leicester Cough Questionnaire. Cough. 2007;3:3.
47. Jones RM, Hilldrup S, Hope-Gill BD, Eccles R, Harrison NK. Mechanical induction of cough in idiopathic pulmonary fibrosis. Cough. 2011;7:2.
48. Kelsall A, Decalmer S, Webster D, et al. How to quantify coughing: correlations with quality of life in chronic cough. Eur Respir J. 2008;32(1):175-179.
49. Key AL, Holt K, Hamilton A, Smith JA, Earis JE. Objective cough frequency in idiopathic pulmonary fibrosis. Cough. 2010;6:4.
50. Ma W, Yu L, Wang Y, Li X, Lü H, Qiu Z. Changes in health-related quality of life and clinical implications in Chinese patients with chronic cough. Cough. 2009;5:7.
51. Morice AH, Menon MS, Mulrennan SA, et al. Opiate therapy in chronic cough. Am J Respir Crit Care Med. 2007;175(4):312-315.
52. Murray MP, Turnbull K, MacQuarrie S, Pentland JL, Hill AT. Validation of the Leicester Cough Questionnaire in non-cystic fibrosis bronchiectasis. Eur Respir J. 2009;34(1):125-131.
53. Polley L, Yaman N, Heaney L, et al. Impact of cough across different chronic respiratory diseases: comparison of two cough-specific health-related quality of life questionnaires. Chest. 2008;134(2):295-302.
54. Raj AA, Pavord DI, Birring SS. Clinical cough IV: what is the minimal important difference for the Leicester Cough Questionnaire? Handb Exp Pharmacol. 2009;(187):311-320.
55. Singapuri A, McKenna S, Brightling CE. The utility of the mannitol challenge in the assessment of chronic cough: a pilot study. Cough. 2008;4:10.
56. Kalpaklioglu AF, Kara T, Kurtipek E, Kocyigit P, Ekici A, Ekici M. Evaluation and impact of chronic cough: comparison of specific vs generic quality-of-life questionnaires. Ann Allergy Asthma Immunol. 2005;94(5):581-585.
57. Field SK, Conley DP, Thawer AM, Leigh R, Cowie RL. Effect of the management of patients with chronic cough by pulmonologists and certified respiratory educators on quality of life: a randomized trial. Chest. 2009;136(4):1021-1028.
58. Shaheen NJ, Crockett SD, Bright SD, et al. Randomised clinical trial: high-dose acid suppression for chronic cough - a double-blind, placebo-controlled study. Aliment Pharmacol Ther. 2011;33(2):225-234.
59. Smith J, Owen E, Earis J, Woodcock A. Cough in COPD: correlation of objective monitoring with cough challenge and subjective assessments. Chest. 2006;130(2):379-385.
60. Chang AB, Robertson CF, Van Asperen PP, et al. A multicenter study on chronic cough in children: burden and etiologies based on a standardized management pathway. Chest. 2012;142(4):943-950.
61. Newcombe PA, Sheffield JK, Chang AB. Minimally important change in a Parent-Proxy Quality-of-Life questionnaire for pediatric chronic cough. Chest. 2011;139(3):576-580.
62. Newcombe PA, Sheffield JK, Juniper EF, Petsky HL, Willis C, Chang AB. Validation of a Parent-Proxy Quality of Life Questionnaire for Paediatric Chronic Cough (PC-QOL). Thorax. 2010;65(9):819-823.
63. Barry SJ, Dane AD, Morice AH, Walmsley AD. The automatic recognition and counting of cough. Cough. 2006;2:8.
64. Coyle MA, Keenan DB, Henderson LS, et al. Evaluation of an ambulatory system for the quantification of cough frequency in patients with chronic obstructive pulmonary disease. Cough. 2005;1:3.
65. Crawford B, Monz B, Hohlfeld J, et al. Development and validation of a cough and sputum assessment questionnaire. Respir Med. 2008;102(11):1545-1555.
66. Freestone C, Eccles R. Assessment of the antitussive efficacy of codeine in cough associated with common cold. J Pharm Pharmacol. 1997;49(10):1045-1049.
67. Hsu JY, Stone RA, Logan-Sinclair RB, Worsdell M, Busst CM, Chung KF. Coughing frequency in patients with persistent cough: assessment using a 24 hour ambulatory recorder. Eur Respir J. 1994;7(7):1246-1253.
68. Kelsall A, Houghton LA, Jones H, Decalmer S, McGuinness K, Smith JA. A novel approach to studying the relationship between subjective and objective measures of cough. Chest. 2011;139(3):569-575.
69. Kelsall A, Decalmer S, McGuinness K, Woodcock A, Smith JA. Sex differences and predictors of objective cough frequency in chronic cough. Thorax. 2009;64(5):393-398.
70. Krahnke J, Gentile D, Angelini B, Danzig M, Skoner D. Comparison of objective and subjective measurements of cough frequency in patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 2004;93(3):259-264.
71. Krajnik M, Damps-Konstanska I, Gorska L, Jassem E. A portable automatic cough analyser in the ambulatory assessment of cough. Biomed Eng Online. 2010;9:17.
72. Leconte S, Liistro G, Lebecque P, Degryse JM. The objective assessment of cough frequency: accuracy of the LR102 device. Cough. 2011;7(1):11.
73. Marsden PA, Smith JA, Kelsall AA, et al. A comparison of objective and subjective measures of cough in asthma. J Allergy Clin Immunol. 2008;122(5):903-907.
74. Matos S, Birring SS, Pavord ID, Evans DH. An automated system for 24-h monitoring of cough frequency: the Leicester Cough Monitor. IEEE Trans Biomed Eng. 2007;54(8):1472-1479.
75. Smith JA, Earis JE, Woodcock AA. Establishing a gold standard for manual cough counting: video versus digital audio recordings. Cough. 2006;2:6.
76. Smith JA, Owen EC, Jones AM, Dodd ME, Webb AK, Woodcock A. Objective measurement of cough during pulmonary exacerbations in adults with cystic fibrosis. Thorax. 2006;61(5):425-429.
77. Smith J, Owen E, Earis J, Woodcock A. Effect of codeine on objective measurement of cough in chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2006;117(4):831-835.
78. Thomas JS, Lyons HA, Shepherd DA. D.A.T.A. - an advanced automated electronic cough counting system for the evaluation of antitussive agents. Curr Ther Res Clin Exp. 1978;23(1):66-77.
79. Woodcock A, McLeod RL, Sadeh J, Smith JA. The efficacy of a NOP1 agonist (SCH486757) in subacute cough. Lung. 2010;188(suppl 1):S47-S52.
80. Hamutcu R, Francis J, Karakoc F, Bush A. Objective monitoring of cough in children with cystic fibrosis. Pediatr Pulmonol. 2002;34(5):331-335.
81. Paul IM, Wai K, Jewell SJ, Shaffer ML, Varadan VV. Evaluation of a new self-contained, ambulatory, objective cough monitor. Cough. 2006;2:7.
82. Archer LN, Simpson H. Night cough counts and diary card scores in asthma. Arch Dis Child. 1985;60(5):473-474.
83. Chang AB, Newman RG, Carlin JB, Phelan PD, Robertson CF. Subjective scoring of cough in children: parent-completed vs child-completed diary cards vs an objective method. Eur Respir J. 1998;11(2):462-466.
84. Chang AB, Newman RG, Phelan PD, Robertson CF. A new use for an old Holter monitor: an ambulatory cough meter. Eur Respir J. 1997;10(7):1637-1639.
85. Chang AB, Phelan PD, Robertson CF, Roberts RG, Sawyer SM. Relation between measurements of cough severity. Arch Dis Child. 2003;88(1):57-60.
86. Corrigan DL, Paton JY. Pilot study of objective cough monitoring in infants. Pediatr Pulmonol. 2003;35(5):350-357.
87. Dales RE, White J, Bhumgara C, McMullen E. Parental reporting of childrens' coughing is biased. Eur J Epidemiol. 1997;13(5):541-545.
88. Falconer A, Oldman C, Helms P. Poor agreement between reported and recorded nocturnal cough in asthma. Pediatr Pulmonol. 1993;15(4):209-211.
89. Fuller P, Picciotto A, Davies M, McKenzie SA. Cough and sleep in inner-city children. Eur Respir J. 1998;12(2):426-431.
90. Hoskyns EW, Thomson A, Decker E, Hutchins A, Simpson H. Effect of controlled release salbutamol on nocturnal cough in asthma. Arch Dis Child. 1991;66(10):1209-1212.
91. Zihlif N, Paraskakis E, Lex C, Van de Pohl LA, Bush A. Correlation between cough frequency and airway inflammation in children with primary ciliary dyskinesia. Pediatr Pulmonol. 2005;39(6):551-557.
92. Irwin RS, Zawacki JK, Wilson MM, French CT, Callery MP. Chronic cough due to gastroesophageal reflux disease: failure to resolve despite total/near-total elimination of esophageal acid. Chest. 2002;121(4):1132-1140.
93. Barnabè R, Berni F, Clini V, et al. The efficacy and safety of moguisteine in comparison with codeine phosphate in patients with chronic cough. Monaldi Arch Chest Dis. 1995;50(2):93-97.
94. Del Donno M, Aversa C, Corsico R, et al. Efficacy and safety of moguisteine in comparison with dextromethorphan in patients with persistent cough. Drug Investigation. 1994;7(2):93-100.
95. Guyatt GH, Townsend M, Kazim F, Newhouse MT. A controlled trial of ambroxol in chronic bronchitis. Chest. 1987;92(4):618-620.
96. Jackson IM, Barnes J, Cooksey P. Efficacy and tolerability of oral acetylcysteine (Fabrol) in chronic bronchitis: a double-blind placebo controlled study. J Int Med Res. 1984;12(3):198-206.
97. Ramsay J, Wright C, Thompson R, Hull D, Morice AH. Assessment of antitussive efficacy of dextromethorphan in smoking related cough: objective vs. subjective measures. Br J Clin Pharmacol. 2008;65(5):737-741.
98. Sabot G, Bagnato A, Frigerio G. Controlled evaluation of the antitussive activity of viminol p-hydroxybenzoate. Int J Clin Pharmacol Biopharm. 1977;15(4):181-183.
99. Newcombe PA, Sheffield JK, Juniper EF, et al. Development of a parentproxy quality-of-life chronic cough-specific questionnaire: clinical impact vs psychometric evaluations. Chest. 2008;133(2):386-395.
100. Birring SS, Fleming T, Matos S, Raj AA, Evans DH, Pavord I D. The Leicester Cough Monitor: preliminary validation of an automated cough detection system in chronic cough. Eur Respir J. 2008;31(5):1013-1018.
101. French CL, Irwin RS, Curley FJ, Krikorian CJ. Impact of chronic cough on quality of life. Arch Intern Med. 1998;158(15):1657-1661.
102. Irwin RS, Curley FJ. The treatment of cough. A comprehensive review. Chest. 1991;99(6):1477-1484.
103. Wewers ME, Lowe NK. A critical review of visual analogue scales in the measurement of clinical phenomena. Res Nurs Health. 1990;13(4):227-236.
104. Gift AG. Validation of a vertical visual analogue scale as a measure of clinical dyspnea. Rehabil Nurs. 1989;14(6):323-325.
105. Wewers ME, Rachfal C, Ahijevych K. A psychometric evaluation of a visual analogue scale of craving for cigarettes. West J Nurs Res. 1990;12(5):672-681.
106. Gift AG. Visual analogue scales: measurement of subjective phenomena. Nurs Res. 1989;38(5):286-288.
107. Juniper EF. Medical questionnaires are copyrighted to ensure that validity is maintained. Chest. 2009;136(4):951-952.
108. Acquadro C, Conway K, Giroudet C, et al. Linguistic Validation Manual for Patient-Reported Outcomes (PRO) Instruments. Lyon, France: MAPI Research Institute; 2004.
109. US Department of Health and Human Services; Food and Drug Administration; Center for Drug Evaluation and Research (CDER); Center for Biologics Evaluation and Research (CBER); Center for Devices and Radiological Health (CDRH). Guidance for Industry: Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. Rockville, MD: Food and Drug Administration; 2009.
110. Streiner DL, Norman GR. Health Measurement Scales: A Practical Guide to Their Development and Use. Oxford, England: Oxford University Press; 2008.
111. Cella D, Yount S, Rothrock N, et al; on behalf of the PROMIS Cooperative Group. Med Care. 2007;45(5)(suppl 1):S3-S11.